Pharmaceuticals in South Korea

Date: September 26, 2016
Pages: 34
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PAE59D33030EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in South Korea
SUMMARY

Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the South Korea pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the South Korea pharmaceuticals market by value in 2015?
  • What will be the size of the South Korea pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in South Korea's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The South Korean pharmaceuticals market had total revenues of $18.2bn in 2015, representing a compound annual growth rate (CAGR) of 1.4% between 2011 and 2015.

South Korea has been classed as a developed pharmaceuticals market since 2010. As such it suffers classic problems that other developed markets are experiencing which will lead to increased spending

The performance of the market is forecast to accelerate, with an anticipated CAGR of 2.3% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $20.4bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
CKD Bio Corporation
Daewoong Pharmaceutical Co., Ltd.
Hanmi Science Co., Ltd.
Pfizer Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: South Korea pharmaceuticals market value: $ billion, 2011-15
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: South Korea pharmaceuticals market share: % share, by value, 2015
Table 4: South Korea pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: CKD Bio Corporation: key facts
Table 6: Daewoong Pharmaceutical Co., Ltd.: key facts
Table 7: Daewoong Pharmaceutical Co., Ltd.: key financials ($)
Table 8: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW)
Table 9: Daewoong Pharmaceutical Co., Ltd.: key financial ratios
Table 10: Hanmi Science Co., Ltd.: key facts
Table 11: Pfizer Inc.: key facts
Table 12: Pfizer Inc.: key financials ($)
Table 13: Pfizer Inc.: key financial ratios
Table 14: South Korea size of population (million), 2011-15
Table 15: South Korea gdp (constant 2005 prices, $ billion), 2011-15
Table 16: South Korea gdp (current prices, $ billion), 2011-15
Table 17: South Korea inflation, 2011-15
Table 18: South Korea consumer price index (absolute), 2011-15
Table 19: South Korea exchange rate, 2011-15

LIST OF FIGURES

Figure 1: South Korea pharmaceuticals market value: $ billion, 2011-15
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: South Korea pharmaceuticals market share: % share, by value, 2015
Figure 4: South Korea pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2015
Figure 11: Daewoong Pharmaceutical Co., Ltd.: revenues and profitability
Figure 12: Daewoong Pharmaceutical Co., Ltd.: assets and liabilities
Figure 13: Pfizer Inc.: revenues and profitability
Figure 14: Pfizer Inc.: assets and liabilities

COMPANIES MENTIONED

CKD Bio Corporation
Daewoong Pharmaceutical Co., Ltd.
Hanmi Science Co., Ltd.
Pfizer Inc.
Skip to top


OTC Pharmaceuticals in South Korea US$ 350.00 Sep, 2016 · 35 pages
The Pharmaceutical Market: South Korea US$ 1,295.00 Jan, 2013 · 123 pages

Ask Your Question

Pharmaceuticals in South Korea
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: